Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer

Journal of Urology

Volumn 194, Issue 5, 2015, Pages 1214-1219

  Blute, Michael L ^a   Rushmer, Timothy J ^a   Shi, Fangfang ^a   Fuller, Benjamin J ^a   Abel, E Jason ^a   Jarrard, David F ^a   Downs, Tracy M ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

Author keywords

angiotensin converting enzyme inhibitors; angiotensin receptor antagonists; local; neoplasm recurrence; renin angiotensin system; urinary bladder neoplasms

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BCG VACCINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; BACILLUS; BLADDER TUMOR; CANCER GROWTH; CANCER RECURRENCE; CANCER SURGERY; ENDOCRINE FUNCTION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; NEPHROURETERECTOMY; NON MUSCLE INVASIVE BLADDER CANCER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENCE FREE SURVIVAL; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR RECURRENCE; CYSTECTOMY; DISEASE FREE SURVIVAL; DRUG THERAPY; EPIDEMIOLOGY; INCIDENCE; NATURAL ORIFICE TRANSLUMINAL ENDOSCOPIC SURGERY; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; SURVIVAL RATE; TRENDS; TUMOR INVASION; UNITED STATES; URETHRA; URINARY BLADDER NEOPLASMS;

AGED; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; NATURAL ORIFICE ENDOSCOPIC SURGERY; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL RATE; URETHRA; URINARY BLADDER NEOPLASMS; WISCONSIN;

EID: 84943630046     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2015.05.104     Document Type: Article

References (26)

1. P.K. Kopparapu, S.A. Boorjian, B.D. Robinson, and et al. Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer Anticancer Res 33 2013 2381
2. D.E. Hansel, J.S. Miller, M.S. Cookson, and et al. Challenges in the pathology of non-muscle-invasive bladder cancer: a dialogue between the urologic surgeon and the pathologist Urology 81 2013 1123
3. M.C. Hall, S.S. Chang, G. Dalbagni, and et al. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update J Urol 178 2007 2314
4. M.S. Cookson, H.W. Herr, Z.F. Zhang, and et al. The treated natural history of high risk superficial bladder cancer: 15-year outcome J Urol 158 1997 62
5. F. Millán-Rodríguez, G. Chéchile-Toniolo, J. Salvador-Bayarri, and et al. Primary superficial bladder cancer risk groups according to progression, mortality and recurrence J Urol 164 2000 680
6. K. Yuge, A. Miyajima, N. Tanaka, and et al. Prognostic value of renin-angiotensin system blockade in non-muscle-invasive bladder cancer Ann Surg Oncol 19 2012 3987
7. E. Escobar, T.S. Rodríguez-Reyna, O. Arrieta, and et al. Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer Curr Vasc Pharmacol 2 2004 385
8. F. Deshayes, and C. Nahmias Angiotensin receptors: a new role in cancer? Trends Endocrinol Metab 16 2005 293
9. A. Miyajima, E. Kikuchi, T. Kosaka, and et al. Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in urogenital cancer Rev Recent Clin Trials 4 2009 75
10. N. Weidner, J.P. Semple, W.R. Welch, and et al. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma N Engl J Med 324 1991 1
11. N. Weidner, P.R. Carroll, J. Flax, and et al. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma Am J Pathol 143 1993 401
12. J. Katada, M. Muramatsu, I. Hayashi, and et al. Significance of vascular endothelial cell growth factor up-regulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas J Pharmacol Exp Ther 302 2002 949
13. M. Muramatsu, J. Katada, M. Hattori, and et al. Chymase mediates mast cell-induced angiogenesis in hamster sponge granulomas Eur J Pharmacol 402 2000 181
14. M. Fujita, I. Hayashi, S. Yamashina, and et al. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis Biochem Biophys Res Commun 294 2002 441
15. M. Okazaki, S. Fushida, S. Harada, and et al. The Angiotensin II type 1 receptor blocker candesartan suppresses proliferation and fibrosis in gastric cancer Cancer Lett 355 2014 46
16. Y.H. Chen, C.H. Huang, H.I. Lu, and et al. Prognostic impact of renin-angiotensin system blockade in esophageal squamous cell carcinoma J Renin Angiotensin Aldosterone Syst 2014 Epub ahead of print
17. T. Suganuma, K. Ino, K. Shibata, and et al. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination Clin Cancer Res 11 2005 2686
18. M. Kosugi, A. Miyajima, E. Kikuchi, and et al. Effect of angiotensin II type 1 receptor antagonist on tumor growth and angiogenesis in a xenograft model of human bladder cancer Hum Cell 20 2007 1
19. T. Kosaka, A. Miyajima, E. Takayama, and et al. Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer Prostate 67 2007 41
20. E.I. Ager, J. Neo, and C. Christophi The renin-angiotensin system and malignancy Carcinogenesis 29 2008 1675
21. B. De Paepe, V.L. Verstraeten, C.R. De Potter, and et al. Growth stimulatory angiotensin II type-1 receptor is upregulated in breast hyperplasia and in situ carcinoma but not in invasive carcinoma Histochem Cell Biol 116 2001 247
22. J.H. Ku, and S.P. Lerner Strategies to prevent progression of high-risk bladder cancer at initial diagnosis Curr Opin Urol 22 2012 405
23. J.P. Sfakianos, P.H. Kim, A.A. Hakimi, and et al. The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Guérin J Urol 191 2014 341
24. N. Tanaka, A. Miyajima, E. Kikuchi, and et al. Prognostic impact of renin-angiotensin system blockade in localised upper-tract urothelial carcinoma Br J Cancer 106 2012 290
25. K. Hoshino, H. Ishiguro, J. Teranishi, and et al. Regulation of androgen receptor expression through angiotensin II type 1 receptor in prostate cancer cells Prostate 71 2011 964
26. H. Uemura, N. Nakaigawa, H. Ishiguro, and et al. Antiproliferative efficacy of angiotensin II receptor blockers in prostate cancer Curr Cancer Drug Targets 5 2005 307